In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...